| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/02/2013 | CA2642130C Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors |
| 04/02/2013 | CA2595544C Compounds having analgesic and/or immunostimulant activity |
| 04/02/2013 | CA2567489C Pyridin-2-one compounds and their use as modulators of the dopamine d3 receptor |
| 04/02/2013 | CA2564085C Heterocyclic amide compound and use thereof as an mmp-13 inhibitor |
| 04/02/2013 | CA2550843C Novel phenylalanine derivatives |
| 04/02/2013 | CA2496565C Non-nucleoside reverse transcriptase inhibitors |
| 04/02/2013 | CA2475633C Heteroaryl compounds useful as inhibitors of gsk-3 |
| 03/28/2013 | WO2013042139A1 Amide compounds, compositions and applications thereof |
| 03/28/2013 | WO2013041811A1 Luminescent probes for biological marking and imagery, and preparation method thereof |
| 03/28/2013 | WO2013041682A1 Novel synthesis method |
| 03/28/2013 | WO2013041652A1 Morpholino substituted urea or carbamate derivatives as mtor inhibitors |
| 03/28/2013 | WO2013041592A1 Stabilizing of organic material with amino-triazine based mannich-compounds |
| 03/28/2013 | WO2013041591A1 New bicyclic dihydroquinoline-2-one derivatives |
| 03/28/2013 | WO2013041480A1 New thio derivatives bearing lactams as potent hdac inhibitors and their uses as medicaments |
| 03/28/2013 | WO2013041461A1 Fsh receptor antagonists |
| 03/28/2013 | WO2013041457A1 N-piperidin-4-yl derivatives |
| 03/28/2013 | WO2013041042A1 Pyrazole carboxamides as janus kinase inhibitors |
| 03/28/2013 | WO2013041038A1 Pyridine compounds as inhibitors of kinase |
| 03/28/2013 | WO2013040801A1 Hydroxamic acid compound containing quinolyl and preparation method thereof, and pharmaceutical composition containing this compound and use thereof |
| 03/28/2013 | WO2013040790A1 Substituted pyrimidines |
| 03/28/2013 | WO2013040789A1 Substituted pyrimidines |
| 03/28/2013 | WO2012173521A3 Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon |
| 03/28/2013 | WO2012168949A3 A process for preparation of nevirapine |
| 03/28/2013 | WO2012151512A3 Bromodomain inhibitors and uses thereof |
| 03/28/2013 | WO2012052491A3 1-(heterocyclic carbonyl)-2-substituted pyrrolidines and their use as fungicides |
| 03/28/2013 | US20130079522 Dihydroethidine analogues and uses thereof |
| 03/28/2013 | US20130079513 N-Thio-anthranilamid compounds and their use as pesticides |
| 03/28/2013 | US20130079365 New bicyclic dihydroquinoline-2-one derivatives |
| 03/28/2013 | US20130079362 Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities |
| 03/28/2013 | US20130079361 Novel iodo pyrimidine derivatives useful for the treatment of macrophage migration inhibitory factor (mif)-implicated diseases and conditions |
| 03/28/2013 | US20130079359 Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma |
| 03/28/2013 | US20130079354 Pyridyl derivatives and their use as therapeutic agents |
| 03/28/2013 | US20130079349 5-amino-3,6-dihydro-1h-pyrazin-2-one derivatives useful as inhibitors of beta-secretase (bace) |
| 03/28/2013 | US20130079347 Novel sulfonylpyrroles |
| 03/28/2013 | US20130079345 Pharmaceutically active disubstituted triazine derivatives |
| 03/28/2013 | US20130079343 1,3,6-Substituted Indole Derivatives Having Inhibitory Activity for Protein Kinase |
| 03/28/2013 | US20130079339 Trpv1 vanilloid receptor antagonists with a bicyclic portion |
| 03/28/2013 | US20130079338 Selective NR2B Antagonists |
| 03/28/2013 | US20130079329 INDAZOLE-3-CARBOXAMIDES AND THEIR USE AS WNT/Beta-CATENIN SIGNALING PATHWAY INHIBITORS |
| 03/28/2013 | US20130079326 N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1 |
| 03/28/2013 | US20130079325 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors |
| 03/28/2013 | US20130079320 Amine Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands |
| 03/28/2013 | US20130079313 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 03/28/2013 | US20130079303 Inhibitors of PI3 Kinase and/or mTOR |
| 03/28/2013 | US20130079302 N-[(het)arylalkyl)] pyrazole(thio)carboxamides and their heterosubstituted analogues |
| 03/28/2013 | US20130078256 Novel hiv reverse transcriptase inhibitors |
| 03/28/2013 | US20130078215 Uses of selective inhibitors of hdac8 for treatment of inflammatory conditions |
| 03/28/2013 | US20130075706 Substituted biaryl compounds for light-emitting devices |
| 03/28/2013 | US20130074927 Highly-fluorescent and photo-stable chromophores for enhanced solar harvesting efficiency |
| 03/28/2013 | CA2858033A1 Quinolyl-containing hydroxamic acid compound and preparation method thereof, and pharmaceutical composition containing this compound and use thereof |
| 03/28/2013 | CA2849726A1 Amide compounds, compositions and applications thereof |
| 03/28/2013 | CA2849234A1 Luminescent probes for biological marking and imagery, and preparation method thereof |
| 03/28/2013 | CA2849189A1 Morpholino substituted urea or carbamate derivatives as mtor inhibitors |
| 03/28/2013 | CA2849176A1 Fsh receptor antagonists |
| 03/28/2013 | CA2849169A1 Pyrazole carboxamides as janus kinase inhibitors |
| 03/28/2013 | CA2849109A1 N-piperidin-4-yl derivatives |
| 03/28/2013 | CA2848788A1 Stabilizing of organic material with amino-triazine based mannich-compounds |
| 03/28/2013 | CA2845170A1 New bicyclic dihydroquinoline-2-one derivatives |
| 03/28/2013 | CA2843211A1 New thio derivatives bearing lactams as potent hdac inhibitors and their uses as medicaments |
| 03/27/2013 | EP2573083A1 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 03/27/2013 | EP2573082A1 Crystalline solvated forms of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole |
| 03/27/2013 | EP2573080A1 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
| 03/27/2013 | EP2573079A2 Benzimidazole quinolinones and uses thereof |
| 03/27/2013 | EP2573072A1 Indenoquinolone compound, preparation method and use thereof |
| 03/27/2013 | EP2571864A1 Piperidinyl-substituted lactams as gpr119 modulators |
| 03/27/2013 | EP2571863A1 Nilotinib salts and crystalline forms thereof |
| 03/27/2013 | EP2571862A1 Prodrug of triazolone compound |
| 03/27/2013 | EP2571860A1 2-phenyl benzoylamides |
| 03/27/2013 | EP2571359A1 Novel prolylcarboxypeptidase inhibitors |
| 03/27/2013 | EP2571352A1 Selective hdac inhibitors |
| 03/27/2013 | CN1972916B 肉桂酰胺类化合物 Cinnamic amides |
| 03/27/2013 | CN1681791B 8-羟基喹啉衍生物 8-hydroxyquinoline derivative |
| 03/27/2013 | CN103003267A Sigma receptor inhibitors |
| 03/27/2013 | CN103003263A Novel hetaryl (thio)carboxamide compounds for controlling invertebrate pests |
| 03/27/2013 | CN103003262A Nitrogenated aromatic heterocyclic ring derivative |
| 03/27/2013 | CN103003252A Process for the preparation of 5-substituted 1-alkyltetrazolyl oxime derivatives |
| 03/27/2013 | CN103003243A Complex compound and optical recording medium containing same |
| 03/27/2013 | CN102993219A Zinc complex, preparation method thereof and application thereof in preparing anti-forgery ink |
| 03/27/2013 | CN102993189A Hydrazone-containing triazolinone compounds and uses thereof |
| 03/27/2013 | CN102993184A Esomeprazole and preparation method of magnesium trihydrate of esomeprazole |
| 03/27/2013 | CN102993183A Pyrrolidine diketone compound containing pyridylaldehyde hydrazone group, preparation method and application of compound |
| 03/27/2013 | CN102993182A Pyrrolidine diketone compound containing pyridine hydrazine group, preparation method and application of compound |
| 03/27/2013 | CN102993181A Preparation method of esomeprazole and preparation method of esomeprazole salt |
| 03/27/2013 | CN102993180A Dendritic blue light metal complex and application thereof and organic light emitting diode device |
| 03/27/2013 | CN102993179A Preparation method of high-purity sodium rabeprazole |
| 03/27/2013 | CN102993178A Isoquinoline compound with Rho kinase inhibition activity and preparation method and application thereof |
| 03/27/2013 | CN102993177A Preparation method of high-purity esomeprazole sodium salt |
| 03/27/2013 | CN102993176A Novel synthetic process of nicosulfuron |
| 03/27/2013 | CN102993175A Dabigatran derivatives, and preparation method and application thereof |
| 03/27/2013 | CN102993174A Dabigatran etexilate derivative as a prodrug |
| 03/27/2013 | CN102993173A Preparation method of revaprzan hydrochloride |
| 03/27/2013 | CN102993172A Tricyclic compound with antihistamine activity, preparation method and application |
| 03/27/2013 | CN102993171A Method for synthesizing quinaphthalone yellow |
| 03/27/2013 | CN102993170A Clinafloxacin derivative as well as preparation method and application thereof |
| 03/27/2013 | CN102993169A Method for refining crude lenalidomide product |
| 03/27/2013 | CN102993168A Streptonigrin analog and preparation method and application thereof |
| 03/27/2013 | CN102993097A Pyrazole amide compound and application thereof |
| 03/27/2013 | CN102993084A Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 03/27/2013 | CN102988362A Useful combinations of monobactam antibiotics with beta-lactamase inhibitors |
| 03/27/2013 | CN102584793B Rabeprazole sodium crystal compound and preparing method thereof |